miR-1291 Functions as a Potential Serum Biomarker for Bullous Pemphigoid

Table 4

Relative expression levels of serum miR-1291 within the different subgroups of bullous pemphigoid (BP) patients.

Subgroups		miR-1291 (2^-ΔCt), median (IQR)	value
Sex
Female	20	0.52 (0.15-1.09)	0.093
Male	25	0.25 (0.09-0.71)
Hypertension
With	14	0.30 (0.12-0.55)	0.520
Without	31	0.31 (0.11-1.01)
Cerebrovascular disease
With	11	0.18 (0.08-0.63)	0.255
Without	34	0.34 (0.15-1.02)
Mucosal involvement
With	10	0.45 (0.15-1.02)	0.677
Without	35	0.31 (0.11-0.88)
CCL17
≤549.0 pg/mL	12	0.13 (0.08-0.24)	0.009
>549.0 pg/mL	33	0.52 (0.16-1.03)
Anti-BP180
0-9 U/mL	7	0.63 (0.08-1.05)	0.915
>9 U/mL	38	0.30 (0.14-0.81)
Anti-BP230
0-9 U/mL	20	0.23 (0.09-0.70)	0.113
>9 U/mL	25	0.63 (0.15-1.09)